Article Text

Download PDFPDF
Featured correspondence
Multivessel revascularisation in ST-elevation myocardial infarction: too early to change the guidelines
  1. Luigi Politi,
  2. Giuseppe Massimo Sangiorgi,
  3. Maria Grazia Modena
  1. Cardiology Department, Policlinico Hospital, University of Modena and Reggio Emilia, Modena, Italy
  1. Correspondence to Dr L Politi, Cardiology Department, Policlinico Hospital, via del Pozzo 71, 41100 Modena, Italy; luigi.politi{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

The Authors' reply: We thank Drs Dambrink and Van 't Hof1 for their interest in our publication.2 This study showed that in the setting of primary angioplasty, patients with multivessel coronary disease treated with complete revascularisation during the index or staged procedure have a reduced rate of long-term major adverse coronary events. In the accompanying editorial,3 Drs Malik and Gerber appoint this study as the ‘justification for complete revascularisation at the time of primary angioplasty’. Indeed, this is the largest randomised trial supporting the results of recent non-randomised or smaller studies that described more benefits with an aggressive rather than a conservative approach in patients with ST-elevation myocardial infarction (STEMI) and diffuse coronary disease.4 5

We are …

View Full Text


  • Linked articles 202945.

  • Competing interests None.

  • Provenance and peer review Commissioned; not externally peer reviewed.

Linked Articles